申请人:Novartis AG
公开号:US10676479B2
公开(公告)日:2020-06-09
A compound of Formula (IA), or a pharmaceutically acceptable salt thereof, is provided that has been shown to be useful for treating a PRC2-mediated disease or disorder:
wherein A, R3, R4, R6, and R7 are as defined herein.
所提供的式 (IA) 化合物或其药学上可接受的盐已被证明可用于治疗 PRC2 介导的疾病或紊乱:
其中 A、R3、R4、R6 和 R7 如本文所定义。